|
ALX Oncology Holdings Common
(ALXO)
|
14.0 |
$312M |
|
4.2M |
73.86 |
|
Instil Bio Common
|
10.0 |
$223M |
|
13M |
17.88 |
|
Harmony Biosciences Holdings Common
(HRMY)
|
8.4 |
$187M |
|
4.9M |
38.33 |
|
New Frontier Health Corp Ord Shs
|
7.2 |
$161M |
|
14M |
11.23 |
|
Amyris Common
|
7.2 |
$160M |
|
12M |
13.73 |
|
Ascendis Pharma A/S Sponsored Adr
(ASND)
|
5.4 |
$121M |
|
761k |
159.39 |
|
Iveric Bio Common
|
4.4 |
$97M |
|
6.0M |
16.24 |
|
Genetron Holdings Ads
|
3.9 |
$88M |
|
6.3M |
13.85 |
|
Tarsus Pharmaceuticals Common
(TARS)
|
2.9 |
$64M |
|
3.0M |
21.55 |
|
Aligos Therapeutics Common
|
2.5 |
$55M |
|
3.5M |
15.51 |
|
Bolt Therapeutics Common
|
2.2 |
$49M |
|
3.9M |
12.65 |
|
Sierra Oncology Common
|
1.9 |
$42M |
|
1.9M |
21.92 |
|
Aadi Bioscience Common
(WHWK)
|
1.9 |
$42M |
|
1.4M |
29.37 |
|
Sinovac Biotech SHS
|
1.7 |
$38M |
|
5.9M |
6.47 |
|
Kadmon Holdings Common
|
1.7 |
$37M |
|
4.3M |
8.71 |
|
Impel NeuroPharma Common
|
1.6 |
$35M |
|
2.9M |
12.18 |
|
Olema Pharmaceuticals Common
(OLMA)
|
1.5 |
$34M |
|
1.2M |
27.56 |
|
Avadel Pharmaceuticals Adr
|
1.3 |
$29M |
|
2.9M |
9.80 |
|
KalVista Pharmaceuticals Common
(KALV)
|
1.3 |
$29M |
|
1.6M |
17.45 |
|
Terns Pharmaceuticals Common
(TERN)
|
1.3 |
$28M |
|
2.7M |
10.42 |
|
Celldex Therapeutics Common
(CLDX)
|
1.2 |
$26M |
|
485k |
53.99 |
|
Legend Biotech Corp Sponsored Sponsored Ads
(LEGN)
|
1.1 |
$25M |
|
489k |
50.56 |
|
Viridian Therapeutics Common
(VRDN)
|
1.0 |
$21M |
|
1.3M |
16.45 |
|
Sera Prognostics Common
(SERA)
|
0.9 |
$21M |
|
1.9M |
11.11 |
|
Zai Lab Adr
(ZLAB)
|
0.8 |
$18M |
|
175k |
105.39 |
|
Aclaris Therapeutics Common
(ACRS)
|
0.8 |
$17M |
|
941k |
18.00 |
|
Mereo Biopharma Group Ads
(MREO)
|
0.8 |
$17M |
|
6.9M |
2.42 |
|
Verona Pharma Ads
(VRNA)
|
0.7 |
$15M |
|
2.7M |
5.48 |
|
Nkarta Common
(NKTX)
|
0.6 |
$14M |
|
512k |
27.81 |
|
Dice Therapeutics Common
|
0.6 |
$13M |
|
410k |
32.75 |
|
Gracell Biotechnologies Sponsored Ads
|
0.6 |
$13M |
|
961k |
13.87 |
|
Curis Common
|
0.5 |
$12M |
|
1.6M |
7.83 |
|
Cogent Biosciences Common
(COGT)
|
0.5 |
$12M |
|
1.4M |
8.41 |
|
Chinook Therapeutics Common
|
0.5 |
$11M |
|
872k |
12.76 |
|
Aurinia Pharmaceuticals Common
(AUPH)
|
0.5 |
$11M |
|
501k |
22.13 |
|
Crinetics Pharmaceuticals Common
(CRNX)
|
0.5 |
$11M |
|
517k |
21.05 |
|
Arcutis Biotherapeutics Common
(ARQT)
|
0.5 |
$10M |
|
434k |
23.89 |
|
Kura Oncology Common
(KURA)
|
0.4 |
$9.8M |
|
525k |
18.73 |
|
Merus NV Common
(MRUS)
|
0.4 |
$9.7M |
|
442k |
22.00 |
|
Dyne Therapeutics Common
(DYN)
|
0.4 |
$9.4M |
|
578k |
16.24 |
|
Codexis Common
(CDXS)
|
0.4 |
$9.0M |
|
388k |
23.26 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.4 |
$8.6M |
|
137k |
62.43 |
|
Essa Pharma Common
(EPIX)
|
0.4 |
$8.4M |
|
1.1M |
8.00 |
|
Zymeworks Common
|
0.4 |
$8.3M |
|
286k |
29.04 |
|
Design Therapeutics Common
(DSGN)
|
0.4 |
$7.8M |
|
531k |
14.69 |
|
Homology Medicines Common
|
0.3 |
$6.7M |
|
853k |
7.87 |
|
Valneva SE Sponsored Ads
(VALN)
|
0.3 |
$6.3M |
|
200k |
31.40 |
|
Syndax Pharmaceuticals Common
(SNDX)
|
0.3 |
$6.1M |
|
320k |
19.11 |
|
Satsuma Pharmaceuticals Common
|
0.3 |
$5.7M |
|
1.2M |
4.66 |
|
Passage Bio Common
|
0.2 |
$5.4M |
|
539k |
9.96 |
|
Aslan Pharmaceuticals Ads
|
0.2 |
$5.1M |
|
2.8M |
1.78 |
|
Larimar Therapeutics Common
(LRMR)
|
0.2 |
$4.6M |
|
400k |
11.53 |
|
Elevation Oncology Common
(ELEV)
|
0.2 |
$3.9M |
|
497k |
7.79 |
|
Eiger BioPharmaceuticals Common
|
0.1 |
$3.1M |
|
470k |
6.68 |
|
Orchard Therapeutics Ads
|
0.1 |
$3.0M |
|
1.3M |
2.30 |
|
10X Genomics CL A Common
(TXG)
|
0.1 |
$2.2M |
|
15k |
145.56 |
|
Precision Biosciences Common
|
0.1 |
$1.6M |
|
140k |
11.54 |
|
Zogenix Common
|
0.1 |
$1.6M |
|
105k |
15.19 |
|
Tricida Common
|
0.0 |
$779k |
|
168k |
4.64 |
|
Metacrine Common
|
0.0 |
$502k |
|
146k |
3.43 |